Source: governmentciomedia.com The Government Accountability Office identified to lawmakers potential use cases for machine learning in drug development to help drive efficiencies and cost savings. The Food and Drug Administration has been tracking the use of artificial intelligence in drug development. Although the FDA does not currently have a regulatory policy around machine learning in drug development, GAO Read More

Read More

Source:-nextgov.com The bureau for years ignored concerns about the accuracy and transparency of its facial recognition efforts, and the House Oversight Committee isn’t happy about it. Lawmakers on Tuesday grilled federal law enforcement officials on the integrity and legality of the government’s facial recognition programs, and criticized the nearly nonexistent oversight Congress has over those Read More

Read More
Artificial Intelligence